{"cluster": 48, "subcluster": 105, "abstract_summ": "Demographic characteristics, laboratory examinations, illness severity, and clinical interventions were compared between patients with COVID-19 with or without cancer as well as between patients with cancer with non-severe or severe COVID-19.The goal of this paper is to identify factors associated with the median duration of hospital stays of COVID-19 patients during the second COVID-19 wave that hit Vietnam from 5 March to 8 April 2020.We also identified advanced tumour stage (OR 2\u00b760, 95% CI 1\u00b705\u20136\u00b743; p=0\u00b7039), elevated tumour necrosis factor \u03b1 (1\u00b722, 1\u00b701\u20131\u00b747; p=0\u00b7037), elevated N-terminal pro-B-type natriuretic peptide (1\u00b765, 1\u00b703\u20132\u00b778; p=0\u00b7032), reduced CD4+ T cells (0\u00b784, 0\u00b771\u20130\u00b798; p=0\u00b7031), and reduced albumin\u2013globulin ratio (0\u00b712, 0\u00b702\u20130\u00b777; p=0\u00b7024) as risk factors of COVID-19 severity in patients with cancer.We aimed to systematically characterise clinical features and determine risk factors of COVID-19 disease severity for patients with cancer and COVID-19.Univariable and multivariable logistic regression, adjusted for age, sex, comorbidities, cancer type, tumour stage, and antitumour treatments, were used to explore risk factors associated with COVID-19 disease severity.", "title_summ": "COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL CampusFactors associated with the duration of hospitalisation among COVID-19 patients in Vietnam: A survival analysisClinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort studyFactors Associated with Hospitalization and Disease Severity in a Racially and Ethnically Diverse Population of COVID-19 Patients", "title_abstract_phrases": "Demographic characteristics, laboratory examinations, illness severity, and clinical interventions were compared between patients with COVID-19 with or without cancer as well as between patients with cancer with non-severe or severe COVID-19.The goal of this paper is to identify factors associated with the median duration of hospital stays of COVID-19 patients during the second COVID-19 wave that hit Vietnam from 5 March to 8 April 2020.Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort studyBACKGROUND: COVID-19 has spread globally.We aimed to systematically characterise clinical features and determine risk factors of COVID-19 disease severity for patients with cancer and COVID-19.We also identified advanced tumour stage (OR 2\u00b760, 95% CI 1\u00b705\u20136\u00b743; p=0\u00b7039), elevated tumour necrosis factor \u03b1 (1\u00b722, 1\u00b701\u20131\u00b747; p=0\u00b7037), elevated N-terminal pro-B-type natriuretic peptide (1\u00b765, 1\u00b703\u20132\u00b778; p=0\u00b7032), reduced CD4+ T cells (0\u00b784, 0\u00b771\u20130\u00b798; p=0\u00b7031), and reduced albumin\u2013globulin ratio (0\u00b712, 0\u00b702\u20130\u00b777; p=0\u00b7024) as risk factors of COVID-19 severity in patients with cancer."}